Symbiotec Pharmalab IPO Subscribed 0.81x on Day 1
5paisa Capital Ltd
- 2 min read
Last Updated: 24th August 2026 - 04:45 pm
Symbiotec Pharmalab IPO was subscribed 0.81 times by 5:24 PM on Day 1, August 24, 2026. The public issue received bids for 1,01,08,635 shares against 1,24,60,533 shares available for subscription. The Employee (EMP) category recorded the highest subscription at 1.59 times, followed by Non-Institutional Investors (NIIs) at 1.03 times. Retail Investors subscribed 0.96 times, while Qualified Institutional Buyers (QIBs) subscribed 0.37 times.
Invest in Indian Markets and Unlock Future Potential With 5paisa!Subscription Status of Symbiotec Pharmalab IPO
| Date | QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|---|
| Day 1 (August 24) | 0.37 | 1.03 | 0.96 | 1.59 | 0.81 |
Here are the subscription details for Symbiotec Pharmalab IPO Day 1, as of 5:24 PM:
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total |
|---|---|---|---|---|
| Anchor | 1 | 53,25,909 | 53,25,909 | 526.200 |
| QIB | 0.37 | 35,50,608 | 13,21,680 | 130.582 |
| NII | 1.03 | 26,62,955 | 27,38,670 | 270.581 |
| Retail | 0.96 | 62,13,562 | 59,95,170 | 592.323 |
| EMP | 1.59 | 33,408 | 53,115 | 5.248 |
| Total | 0.81 | 1,24,60,533 |
1,01,08,635 |
998.733 |
Key Highlights – Day 1
- Overall subscription stood at 0.81 times on Day 1 (August 24, 2026).
- Qualified Institutional Buyers (QIBs) subscribed 0.37 times.
- Non-Institutional Investors (NIIs) subscribed 1.03 times.
- Retail Investors subscribed 0.96 times.
- Employee (EMP) category subscribed 1.59 times, the highest.
About Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited is a research-driven pharmaceutical and biotechnology company focused on active pharmaceutical ingredients (APIs) and complex pharmaceutical products. The company has capabilities across organic chemistry, biotechnology and complex injectables, with a significant presence in corticosteroid and steroidal-hormone APIs. Its portfolio also includes fermentation-based APIs and contract development and manufacturing services for pharmaceutical and nutraceutical companies. The company operates manufacturing facilities at Rau and Pithampur in Madhya Pradesh and supplies products to global markets.
- FREE IPO Application
- Apply with Ease
- Pre-Apply for IPOs
- UPI Bid Instantly
Trending on 5paisa
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.